Calliditas Therapeutics AB - ADR (CALT) Company Profile & Statistics

Calliditas Therapeutics AB - ADR
CALT
(Nasdaq - US)
N/A
20.69
+1.69 (+8.88%)
in:usd•As of: May 03, 2024 10:59 UTC -4
Open
20.69
High
20.69
Low
20.69

About Calliditas Therapeutics AB - ADR

CEO

Ren¿e Aguiar

Headquarters

kungsbron 1, c8

stockholm, v7 11122, sweden

Auditor

Ernst & Young AB

Employees

178

Share Holders

N/A

Website

www.calliditas.se

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Calliditas Therapeutics AB is a specialty pharmaceutical company. It is focused on developing pharmaceutical products for patients with a significant unmet medical need. The compnay's lead candidate consist Nefecon. Calliditas Therapeutics AB is based in Stockholm, Sweden.

Calliditas Therapeutics AB - ADR Statistics

Valuation Measures

Market Capitalization ²	616.36M
Enterprise Value	615.68M
Enterprise Value/EBITDA (ttm)	-18.18
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	18.81
Price to Sales (ttm)	5.23
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	95.78%
Operating Margin (ttm)	-38.72%
Profit Margin (ttm)	-46.31%
Return on Equity (ttm)	-104.47%
Return on Invested Capital (ttm)	-35.02%
Return on Assets (ttm)	-26.75%

Income Statement

Revenue (ttm)	114.19M
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	109.81M
EBITDA (ttm)³	-33.86M
Net Income Avi to Common (ttm)	-40.50M
Diluted EPS (ttm)	-1.64

Share Statistics

Beta (5Y Monthly)	1.50
52-Week Change	-17.64%
S&P500 52-Week Change	26.46%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	29.14M
% Held by Insiders	2.20%
% Held by Institutions	2.83%

Balance Sheet

Total Cash (mrq)	91.82M
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	91.15M
Total Debt/Equity (mrq)	218.53%
Current Ratio (mrq)	3.01%
Quick Ratio (mrq)	3.08%
Book Value Per Share (mrq)	1.21

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.58
Free Cash Flow (ytd)	-42.32M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Calliditas Therapeutics AB - ADR

Trade With A Regulated Broker